A citation-based method for searching scientific literature

Patrice Watson, Hans F A Vasen, Jukka-Pekka Mecklin, Inge Bernstein, Markku Aarnio, Heikki J Järvinen, Torben Myrhøj, Lone Sunde, Juul T Wijnen, Henry T Lynch. Int J Cancer 2008
Times Cited: 371







List of co-cited articles
730 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, Sophie Grandjouan, Laetitia Huiart, Michel Longy, Rosine Guimbaud, Bruno Buecher, Yves-Jean Bignon, Olivier Caron,[...]. JAMA 2011
593
37

Risks of less common cancers in proven mutation carriers with lynch syndrome.
Christoph Engel, Markus Loeffler, Verena Steinke, Nils Rahner, Elke Holinski-Feder, Wolfgang Dietmaier, Hans K Schackert, Heike Goergens, Magnus von Knebel Doeberitz, Timm O Goecke,[...]. J Clin Oncol 2012
176
28

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
26

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.
Pål Møller, Toni T Seppälä, Inge Bernstein, Elke Holinski-Feder, Paulo Sala, D Gareth Evans, Annika Lindblom, Finlay Macrae, Ignacio Blanco, Rolf H Sijmons,[...]. Gut 2018
215
23


PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
20

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.
E Barrow, L Robinson, W Alduaij, A Shenton, T Clancy, F Lalloo, J Hill, D G Evans. Clin Genet 2009
194
19

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Sapna Syngal, Randall E Brand, James M Church, Francis M Giardiello, Heather L Hampel, Randall W Burt. Am J Gastroenterol 2015
680
19

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Hidewaki Nakagawa, Kaisa Sotamaa, Thomas W Prior, Judith Westman,[...]. N Engl J Med 2005
923
16

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer.
Francis M Giardiello, John I Allen, Jennifer E Axilbund, C Richard Boland, Carol A Burke, Randall W Burt, James M Church, Jason A Dominitz, David A Johnson, Tonya Kaltenbach,[...]. Gastroenterology 2014
253
16

Hereditary colorectal cancer.
Henry T Lynch, Albert de la Chapelle. N Engl J Med 2003
15

Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
Patrick Joost, Christina Therkildsen, Mev Dominguez-Valentin, Mats Jönsson, Mef Nilbert. Urology 2015
44
34

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.
Hans F A Vasen, Ignacio Blanco, Katja Aktan-Collan, Jessica P Gopie, Angel Alonso, Stefan Aretz, Inge Bernstein, Lucio Bertario, John Burn, Gabriel Capella,[...]. Gut 2013
427
15

Identification of Lynch syndrome among patients with colorectal cancer.
Leticia Moreira, Francesc Balaguer, Noralane Lindor, Albert de la Chapelle, Heather Hampel, Lauri A Aaltonen, John L Hopper, Loic Le Marchand, Steven Gallinger, Polly A Newcomb,[...]. JAMA 2012
303
15

Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Heather Hampel, Wendy L Frankel, Edward Martin, Mark Arnold, Karamjit Khanduja, Philip Kuebler, Mark Clendenning, Kaisa Sotamaa, Thomas Prior, Judith A Westman,[...]. J Clin Oncol 2008
547
14

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
928
14

Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Kathleen M Schmeler, Henry T Lynch, Lee-may Chen, Mark F Munsell, Pamela T Soliman, Mary Beth Clark, Molly S Daniels, Kristin G White, Stephanie G Boyd-Rogers, Peggy G Conrad,[...]. N Engl J Med 2006
472
14

Cancer risk in mutation carriers of DNA-mismatch-repair genes.
M Aarnio, R Sankila, E Pukkala, R Salovaara, L A Aaltonen, A de la Chapelle, P Peltomäki, J P Mecklin, H J Järvinen. Int J Cancer 1999
812
14

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
Pål Møller, Toni Seppälä, Inge Bernstein, Elke Holinski-Feder, Paola Sala, D Gareth Evans, Annika Lindblom, Finlay Macrae, Ignacio Blanco, Rolf Sijmons,[...]. Gut 2017
237
13

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
13

Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands.
Lisette G Capelle, Nicole C T Van Grieken, Hester F Lingsma, Ewout W Steyerberg, Willem J Klokman, Marco J Bruno, Hans F A Vasen, Ernst J Kuipers. Gastroenterology 2010
127
13

Milestones of Lynch syndrome: 1895-2015.
Henry T Lynch, Carrie L Snyder, Trudy G Shaw, Christopher D Heinen, Megan P Hitchins. Nat Rev Cancer 2015
345
12

Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.
R S van der Post, L A Kiemeney, M J L Ligtenberg, J A Witjes, C A Hulsbergen-van de Kaa, D Bodmer, L Schaap, C M Kets, J H J M van Krieken, N Hoogerbrugge. J Med Genet 2010
115
12



The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).
H F Vasen, J P Mecklin, P M Khan, H T Lynch. Dis Colon Rectum 1991
11

Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.
Aung Ko Win, Mark A Jenkins, James G Dowty, Antonis C Antoniou, Andrew Lee, Graham G Giles, Daniel D Buchanan, Mark Clendenning, Christophe Rosty, Dennis J Ahnen,[...]. Cancer Epidemiol Biomarkers Prev 2017
150
11

Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.
Elena Stoffel, Bhramar Mukherjee, Victoria M Raymond, Nabihah Tayob, Fay Kastrinos, Jennifer Sparr, Fei Wang, Prathap Bandipalliam, Sapna Syngal, Stephen B Gruber. Gastroenterology 2009
234
11

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
11

Risks of Lynch syndrome cancers for MSH6 mutation carriers.
Laura Baglietto, Noralane M Lindor, James G Dowty, Darren M White, Anja Wagner, Encarna B Gomez Garcia, Annette H J T Vriends, Nicola R Cartwright, Rebecca A Barnetson, Susan M Farrington,[...]. J Natl Cancer Inst 2010
232
11

Cancer Risks for PMS2-Associated Lynch Syndrome.
Sanne W Ten Broeke, Heleen M van der Klift, Carli M J Tops, Stefan Aretz, Inge Bernstein, Daniel D Buchanan, Albert de la Chapelle, Gabriel Capella, Mark Clendenning, Christoph Engel,[...]. J Clin Oncol 2018
80
13

Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.
Heather Hampel, Julie A Stephens, Eero Pukkala, Risto Sankila, Lauri A Aaltonen, Jukka-Pekka Mecklin, Albert de la Chapelle. Gastroenterology 2005
277
10

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
Leigha Senter, Mark Clendenning, Kaisa Sotamaa, Heather Hampel, Jane Green, John D Potter, Annika Lindblom, Kristina Lagerstedt, Stephen N Thibodeau, Noralane M Lindor,[...]. Gastroenterology 2008
345
10

MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
H F Vasen, A Stormorken, F H Menko, F M Nagengast, J H Kleibeuker, G Griffioen, B G Taal, P Moller, J T Wijnen. J Clin Oncol 2001
267
10

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.
Marjolijn J L Ligtenberg, Roland P Kuiper, Tsun Leung Chan, Monique Goossens, Konnie M Hebeda, Marsha Voorendt, Tracy Y H Lee, Danielle Bodmer, Eveline Hoenselaar, Sandra J B Hendriks-Cornelissen,[...]. Nat Genet 2009
481
9

A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
François Audenet, Pierre Colin, David R Yates, Adil Ouzzane, Géraldine Pignot, Jean-Alexandre Long, Michel Soulie, Véronique Phé, Henri Bensadoun, Laurent Guy,[...]. BJU Int 2012
43
20

Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome.
Holly L Harper, Jesse K McKenney, Brandie Heald, Andrew Stephenson, Steven C Campbell, Thomas Plesec, Cristina Magi-Galluzzi. Mod Pathol 2017
34
26

Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
Maureen Mork, Scott G Hubosky, Morgan Rouprêt, Vitaly Margulis, Jay Raman, Yair Lotan, Timothy O'Brien, Nancy You, Shahrokh F Shariat, Surena F Matin. J Urol 2015
38
23

Risk of pancreatic cancer in families with Lynch syndrome.
Fay Kastrinos, Bhramar Mukherjee, Nabihah Tayob, Fei Wang, Jennifer Sparr, Victoria M Raymond, Prathap Bandipalliam, Elena M Stoffel, Stephen B Gruber, Sapna Syngal. JAMA 2009
289
9

Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Heather Hampel, Wendy Frankel, Jenny Panescu, Janet Lockman, Kaisa Sotamaa, Daniel Fix, Ilene Comeras, Jennifer La Jeunesse, Hidewaki Nakagawa, Judith A Westman,[...]. Cancer Res 2006
389
9

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
353
9

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
215
9

Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Sean C Skeldon, Kara Semotiuk, Melyssa Aronson, Spring Holter, Steven Gallinger, Aaron Pollett, Cynthia Kuk, Bas van Rhijn, Peter Bostrom, Zane Cohen,[...]. Eur Urol 2013
58
15

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.
Francis M Giardiello, John I Allen, Jennifer E Axilbund, C Richard Boland, Carol A Burke, Randall W Burt, James M Church, Jason A Dominitz, David A Johnson, Tonya Kaltenbach,[...]. Am J Gastroenterol 2014
269
9

Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.
Sigurdis Haraldsdottir, Heather Hampel, Jerneja Tomsic, Wendy L Frankel, Rachel Pearlman, Albert de la Chapelle, Colin C Pritchard. Gastroenterology 2014
234
8

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.
Glenn E Palomaki, Monica R McClain, Stephanie Melillo, Heather L Hampel, Stephen N Thibodeau. Genet Med 2009
327
8

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.
H T Lynch, P M Lynch, S J Lanspa, C L Snyder, J F Lynch, C R Boland. Clin Genet 2009
490
8

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.
Marlies J E Kempers, Roland P Kuiper, Charlotte W Ockeloen, Pierre O Chappuis, Pierre Hutter, Nils Rahner, Hans K Schackert, Verena Steinke, Elke Holinski-Feder, Monika Morak,[...]. Lancet Oncol 2011
168
8

Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study.
Aung Ko Win, Joanne P Young, Noralane M Lindor, Katherine M Tucker, Dennis J Ahnen, Graeme P Young, Daniel D Buchanan, Mark Clendenning, Graham G Giles, Ingrid Winship,[...]. J Clin Oncol 2012
207
8

Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer.
N A J Ryan, D G Evans, K Green, E J Crosbie. Gynecol Oncol 2017
39
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.